Blog

BLOG: What’s ahead in 2019

December 14, 2018
If you want to know the future, look no further than the FDA’s coming Prescription Drug User Fee Act announcements calendar. While not all…
In the JournalsPerspective

Increase in choroidal thickness seen after CPAP therapy

December 14, 2018
Patients with obstructive sleep apnea syndrome who underwent continuous positive airway pressure therapy experienced an increase in choroidal…

Blogs by David Khorram, MD, focus on global ophthalmology

December 14, 2018
In 2018, Healio.com/OSN introduced a new blogger, David Khorram, MD, who writes about global ophthalmology and issued related to combating global…

OD-OS releases software for iridotomy treatment with Navilas 577s laser

December 14, 2018
OD-OS has released new software for the Navilas 577s retinal laser system. The version 3.5 software includes an intuitive anterior segment treatment…

Catch up with Dr. White’s ‘The Dry Eye’

December 13, 2018
Darrell E. White, MD, writes a monthly column in Ocular Surgery News discussing issues related to dry eye disease. Catch up with his 2018 articles…

New technology detects firing of nerve cells

December 13, 2018
Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of…

Gene therapy fails to show clinical activity in X-linked retinoschisis

December 13, 2018
An investigational AAV-based gene therapy from Applied Genetic Technologies Corporation for X-linked retinoschisis due to mutations in the RS1 gene…
Meeting NewsVideo

VIDEO: Presbyopia correction: How to choose between EDOF, MTF or mix-and-match IOLs

December 13, 2018
NEW YORK — From OSN New York 2018, Maria C. Scott, MD, founder of Chesapeake Eye Care and Laser Center in Annapolis, Maryland, gives her…

Europe’s Luxturna approval tops November retina news

December 12, 2018
The European Commission’s approval of Luxturna for inherited retinal disease was the most-read retina-related article on Healio.com/OSN in…

Aerpio posts quarterly net income

December 12, 2018
Aerpio Pharmaceuticals reported a net income of $11.5 million, or $0.28 per share, in the third quarter of 2018 compared with a net loss of $4.6…

Quality of life improvements sustained in trial of GenSight’s LHON treatment

December 12, 2018
GS010 for Leber hereditary optic neuropathy demonstrated quality of life improvements in a phase 3 clinical trial, GenSight Biologics announced in a…
Meeting NewsVideo

VIDEO: Nuclear disassembly: The new divide and conquer

December 12, 2018
NEW YORK — From OSN New York 2018, Jennifer Loh, MD, of Loh Ophthalmology Associates of Miami, gives her presentation on the miLOOP…

BLOG: How to get involved with international ophthalmology

December 11, 2018
While at the American Academy of Ophthalmology meeting this year, quite a few people approached me, asking, “Hey, I’ve got a week or two…

Anthem Blue Cross Blue Shield to cover Avedro’s corneal cross-linking

December 11, 2018
Anthem Blue Cross Blue Shield will cover Avedro’s Photrexa formulations and KXL System for corneal cross-linking, the company announced in a…

AAO: Keep safety standards high in scope-of-practice expansions

December 11, 2018
The American Academy of Ophthalmology agrees with a joint federal report’s recommendations on scope of practice, the organization announced in…

Mazzo named OCTANe board chairman

December 11, 2018
OCTANe has appointed Jim Mazzo as the chairman of its board of directors, according to a press release. Mazzo, global president of ophthalmic…
Feature

How US-Canada-Mexico trade deal could impact drug prices, research

December 11, 2018
The United States-Mexico-Canada Agreement keeps drug prices high but could potentially spur new research opportunities, a pharmaceutical expert told…

FDA approves Alembic’s allergic conjunctivitis treatment

December 10, 2018
The FDA has approved an abbreviated new drug application for olopatadine hydrochloride ophthalmic solution 0.1%, Alembic Pharmaceuticals announced in…

Verkazia approved in Scotland for vernal keratoconjunctivitis in children, adolescents

December 10, 2018
The Scottish Medicines Consortium has approved Verkazia eye drop emulsion for the treatment of vernal keratoconjunctivitis in children from 4 years…

Akorn loses Fresenius appeal; CEO to step down

December 10, 2018
The Delaware Supreme Court upheld a lower court decision allowing Fresenius Kabi to back out of a $4.3 billion acquisition of Akorn, prompting Akorn…